Avoro Life Sciences Fund LLC
Avoro Life Sciences Fund LLC is a hedge fund based in New York, New York. According to its most recent Form D, filed May 1, 2026, the fund has sold $3,454,353,055 of interests to 292 investors since its first sale in Jul 2010. The minimum investment it accepts from an outside investor is $1,000,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Behzad Aghazadeh; Avoro Capital GP, LLC; Avoro Capital Advisors LLC.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
The firm that manages it, Avoro Capital Advisors LLC, files Form 13F. Its page shows the firm's disclosed stock holdings and an estimate derived from them. Those figures describe the firm as a whole, not this fund.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $3,454,353,055Cumulative sales reported on Form D
- Investors
- 292
- First sale
- Jul 1, 2010
- Minimum investment
- $1,000,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Behzad Aghazadeh; Avoro Capital GP, LLC; Avoro Capital Advisors LLC
- Latest Form D
- May 1, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| May 1, 2026 | Form D/A (amendment) | $3,454,353,055 | 292 | SEC.gov ↗ |
| May 2, 2025 | Form D/A (amendment) | $3,333,063,805 | 291 | SEC.gov ↗ |
| May 2, 2024 | Form D/A (amendment) | $3,165,551,019 | 283 | SEC.gov ↗ |
| May 2, 2023 | Form D/A (amendment) | $2,836,643,254 | 265 | SEC.gov ↗ |
| May 2, 2022 | Form D/A (amendment) | $2,467,045,017 | 251 | SEC.gov ↗ |
| May 3, 2021 | Form D/A (amendment) | $1,965,008,017 | 224 | SEC.gov ↗ |
| May 6, 2020 | Form D/A (amendment) | $1,655,581,767 | 192 | SEC.gov ↗ |
| May 22, 2019 | Form D/A (amendment) | $1,270,284,267 | 169 | SEC.gov ↗ |
| Sep 7, 2018 | Form D/A (amendment) | $1,200,334,242 | 159 | SEC.gov ↗ |
| Oct 11, 2017 | Form D/A (amendment) | $629,891,742 | 129 | SEC.gov ↗ |
| Oct 11, 2016 | Form D/A (amendment) | $412,916,742 | 108 | SEC.gov ↗ |
| Oct 9, 2015 | Form D/A (amendment) | $292,582,529 | 96 | SEC.gov ↗ |
13 Form D filings in the SEC's electronic records (2008 onward), the earliest on Oct 17, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Showing the latest 12 of 13 filings; the rest are on SEC.gov. Source: U.S. Securities and Exchange Commission, Form D data sets.
Vehicles of this fund (2)
| Legal name on Form D | SEC CIK | Location reported | Total raised | Investors | Minimum | Latest Form D |
|---|---|---|---|---|---|---|
| Avoro Life Sciences Fund LLC (main vehicle on this page) | 1498991 | New York, New York | $3,454,353,055 | 292 | $1,000,000 | May 1, 2026 |
| Avoro Life Sciences Offshore Fund Ltd. | 1498990 | New York, New York | $2,180,159,075 | 290 | $1,000,000 | May 1, 2026 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of Avoro Life Sciences Fund LLC, the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.
Raise history: Avoro Life Sciences Offshore Fund Ltd.
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| May 1, 2026 | Form D/A (amendment) | $2,180,159,075 | 290 | SEC.gov ↗ |
| May 2, 2025 | Form D/A (amendment) | $2,109,979,075 | 278 | SEC.gov ↗ |
| May 2, 2024 | Form D/A (amendment) | $1,996,916,290 | 259 | SEC.gov ↗ |
| May 2, 2023 | Form D/A (amendment) | $1,768,599,025 | 248 | SEC.gov ↗ |
| May 2, 2022 | Form D/A (amendment) | $1,447,449,025 | 229 | SEC.gov ↗ |
| May 3, 2021 | Form D/A (amendment) | $1,084,074,025 | 185 | SEC.gov ↗ |
| May 6, 2020 | Form D/A (amendment) | $927,339,025 | 160 | SEC.gov ↗ |
| May 22, 2019 | Form D/A (amendment) | $674,899,025 | 147 | SEC.gov ↗ |
| Sep 7, 2018 | Form D/A (amendment) | $642,799,000 | 146 | SEC.gov ↗ |
| Oct 11, 2017 | Form D/A (amendment) | $360,999,000 | 121 | SEC.gov ↗ |
| Oct 11, 2016 | Form D/A (amendment) | $249,289,000 | 96 | SEC.gov ↗ |
| Oct 9, 2015 | Form D/A (amendment) | $178,486,500 | 82 | SEC.gov ↗ |
13 Form D filings in the SEC's electronic records (2008 onward), the earliest on Oct 17, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Showing the latest 12 of 13 filings; the rest are on SEC.gov. Source: U.S. Securities and Exchange Commission, Form D data sets.
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Fundacao Calouste Gulbenkian | — | $23,487,267 | fair market value | Dec 31, 2024 |
1 private foundation listed this fund by name among the investments on its IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Foundations that report holding this fund: Avoro Life Sciences Offshore Fund Ltd.
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Edward P Evans Foundation | MA | $5,048,248 | fair market value | Nov 30, 2025 |
| Joyce and Irving Goldman Family | NY | $2,279,463 | fair market value | Dec 31, 2024 |
| The David Berg Foundation Inc | NY | $1,229,935 | fair market value | Dec 31, 2024 |
| George L Ohrstrom Foundation | FL | $1,202,697 | fair market value | Dec 31, 2024 |
| Redlich Horwitz Foundation | NY | $106,795 | fair market value | Dec 31, 2024 |
5 private foundations listed this fund by name among the investments on their IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about Avoro Life Sciences Fund LLC
What is the minimum investment for Avoro Life Sciences Fund LLC?
According to its latest Form D, filed May 1, 2026, the minimum investment Avoro Life Sciences Fund LLC accepts from an outside investor is $1,000,000.
Who can invest in Avoro Life Sciences Fund LLC?
Avoro Life Sciences Fund LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Avoro Life Sciences Fund LLC raised?
Avoro Life Sciences Fund LLC reports $3,454,353,055 sold from 292 investors on its Form D filed May 1, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Avoro Life Sciences Fund LLC based?
Avoro Life Sciences Fund LLC is based in New York, New York and is managed by Avoro Capital Advisors LLC.
When did Avoro Life Sciences Fund LLC launch?
Avoro Life Sciences Fund LLC reports its first sale in Jul 2010.
Size compared with every hedge fund
Raised more than 97% of the 2,527 hedge funds based in New York, and more than 98% of all 10,141 that report sales.